Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (PolarisDMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03703882
Recruitment Status : Completed
First Posted : October 12, 2018
Last Update Posted : November 20, 2020
Sponsor:
Information provided by (Responsible Party):
Catabasis Pharmaceuticals